Federal preemption and its impact on state restrictions limiting access to mifepristone and abortion care

Session Overview

The FDA’s Risk Evaluation and Mitigation Strategy (REMS) for mifepristone allows patients to obtain the drug without an in-person visit to a clinician. Ongoing federal litigation has challenged the FDA’s REMS for mifepristone, seeking to add or remove restrictions. In the meantime, mifepristone access is being undermined by additional restrictions at the state level, imposed by state law. Doctors and lawyers are now working together to challenge these state restrictions and ensure that the FDA, not state legislatures, makes the rules for access to mifepristone. This session will explore the role of the law of federal preemption, its impact on practicing medicine, and how clinicians can get involved.

Key Takeaways

• Educate physicians on current state legislation restricting use of mifepristone that directly conflicts with FDA REMS.
• Explain the role of federal preemption and how upholding current, restrictive state laws could have a broader impact on: 
  • access to other drugs, ex. HIV PrEP and opioids;
  • inflict widespread harms on the medical profession;
  • inflict widespread harms on patients.
• Encourage physicians to engage on these issues; highlight the case of Bryant vs. Stein and the need to support this challenge.

Featured Speakers

Chris Morten, JD, PhD

Skye L. Perryman, JD

Claire Huang

Isaiah Levinson

How to Attend

📅 Date: Thursday, December 5th, 2024
🕗 Time: 8:00 – 9:00 PM (ET) / 5:00 – 6:00 PM (PT)
📍 Location: Live Stream Event
🔗 Registration: Click here to register

About the Advocacy Grand Rounds

The purpose of our Advocacy Grand Rounds series is to provide physicians, medical trainees, and other health care professionals in our network with monthly trainings and courses to supplement their advocacy efforts. Members have the opportunity to obtain CME credits for specially accredited 1-hour events.

Don’t miss this opportunity to learn from leaders in healthcare advocacy and to begin integrating electoral advocacy into your professional journey!